GAMMA Investing’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.97M Buy
6,401
+1,317
+26% +$408K 0.07% 228
2026
Q2
$1.42M Sell
5,084
-105
-2% -$27.6K 0.05% 296
2026
Q1
$1.38M Buy
5,189
+802
+18% +$217K 0.06% 254
2025
Q4
$1.1M Buy
4,387
+7
+0.2% +$1.86K 0.06% 290
2025
Q3
$1.26M Buy
4,380
+547
+14% +$147K 0.07% 234
2025
Q2
$1.01M Buy
3,833
+354
+10% +$86.2K 0.06% 271
2025
Q1
$810K Buy
3,479
+1,316
+61% +$319K 0.06% 285
2024
Q4
$496K Buy
2,163
+562
+35% +$129K 0.04% 363
2024
Q3
$358K Buy
1,601
+484
+43% +$106K 0.04% 410
2024
Q2
$227K Buy
1,117
+374
+50% +$76.1K 0.03% 462
2024
Q1
$162K Buy
743
+32
+5% +$7.05K 0.03% 463
2023
Q4
$158K Buy
+711
New +$149K 0.04% 378

Other funds holding LH

GAMMA Investing's LH Position: Q3 2026 in Review

GAMMA Investing increased its Labcorp (LH) stake by 26% in Q3 2026, buying an estimated $408K and bringing the position to 6,401 shares worth $1.97M. The position accounts for 0.07% of the portfolio, ranked #228.

GAMMA Investing first reported a position in LH in Q4 2023 and has held it in 12 quarters since. 32 funds tracked by Wall St. Rank hold LH as of Q3 2026.

  • GAMMA Investing held 6,401 shares of Labcorp worth $1.97M as of Q3 2026.
  • GAMMA Investing bought 1,317 Labcorp shares in Q3 2026, an estimated $408K.
  • Labcorp made up 0.07% of GAMMA Investing's portfolio in Q3 2026, its #228 holding.
  • GAMMA Investing first reported a position in Labcorp in Q4 2023 and has held it in 12 quarters since.
  • 32 funds tracked by Wall St. Rank held Labcorp as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.